Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06277245
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-02-02
Brief Title:
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis
Sponsor:
Lynk Pharmaceuticals Co Ltd
Organization:
Lynk Pharmaceuticals Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-02
First Submit QC Date:
February 17 2024
Study First Post Date:
2024-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-19
Last Update Post Date:
2024-03-20
Last Update Post Date Type:
ACTUAL